These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2705632)

  • 1. Effects of 3-glucosaminoglycan sulfate on hemorheologic parameters in hyperlipidemic peripheral vascular disease (PVD) patients: a preliminary double-blind crossover study.
    Ciuffetti G; Mercuri M; Susta A; Lupattelli G; Pasqualini L; Lombardini R; Mannarino E
    Angiology; 1989 Apr; 40(4 Pt 1):255-9. PubMed ID: 2705632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of sulodexide on hemorheological parameters in a group of patients with peripheral arteriosclerotic vascular disease].
    Calabrò A; Rossi A; Baiocchi MR; Coscetti G; Fellin R; Crepaldi G
    Ric Clin Lab; 1985; 15 Suppl 1():455-63. PubMed ID: 4035227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
    Crepaldi G; Fellin R; Calabrò A; Baiocchi MR; Rossi A; Lenzi S; Descovich GC; Delmonte G; Gaddi A; Ventura A
    Monogr Atheroscler; 1986; 14():215-21. PubMed ID: 3526129
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic approach to the diagnosis and treatment of atherosclerotic peripheral vascular disease.
    Montanari G; Vaccarino V; Franceschini G; Sirtori M; Bondioli A; Sirtori CR
    Int Angiol; 1987; 6(4):339-49. PubMed ID: 3330115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind multicenter trial on a new medium molecular weight glycosaminoglycan. Current therapeutic effects and perspectives for clinical use.
    Crepaldi G; Fellin R; Calabrò A; Rossi A; Ventura A; Mannarino E; Senin U; Ciuffetti G; Descovich GC; Gaddi A
    Atherosclerosis; 1990 Apr; 81(3):233-43. PubMed ID: 2190565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
    Espinosa RA; Rodríguez-Roa E; Nagy E; Mijares ME; Rodríguez-Larralde A; Gil A; Lundberg U; Carvajal Z; Castillo L; Arocha-Piñango CL
    Invest Clin; 2006 Mar; 47(1):35-48. PubMed ID: 16562643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
    Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
    Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood rheology changes during bezafibrate treatment.
    Caimi G; Francavilla G; Romano A; Catania A; Santonocito G; Sarno A
    Br J Clin Pract; 1988 Nov; 42(11):456-8. PubMed ID: 3076782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood and plasma viscosity after acipimox treatment in hypertriglyceridemic patients.
    Montefusco S; Iannaci G; Gnasso A; Cortese C; Lamenza F; Postiglione A
    Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):492-4. PubMed ID: 3235215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension.
    Toth K; Nemes J; Czopf L; Kapronczay P; Kesmarky G; Juricskay I
    Clin Hemorheol Microcirc; 1999; 20(1):57-61. PubMed ID: 11185685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rapid effect of glucuronyl glucosamine glycan sulfate on the blood levels of HDL-cholesterol in vascular diseases].
    Ferlito S; La Spina E; Cultrera E; Puleo F; Carrà G
    Arch Sci Med (Torino); 1982; 139(2):175-81. PubMed ID: 7138283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
    Ciuffetti G; Sokola E; Lombardini R; Pasqualini L; Pirro M; Mannarino E
    Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
    Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
    Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
    Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K
    Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
    Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
    Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemorrheology and quality of life in fibrinogen- and lipid-lowering therapy].
    Walzl M; Lechner H; Walzl B; Kleinert G; Schied G; Freidl W; Bertha G
    Schweiz Med Wochenschr; 1993 Oct; 123(40):1875-82. PubMed ID: 8211041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowering of plasma viscosity by the oral administration of the glycosaminoglycan sulodexide in patients with peripheral vascular disease.
    Lunetta M; Salanitri T
    J Int Med Res; 1992 Feb; 20(1):45-53. PubMed ID: 1568519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemocoagulation and hemorheology in heart failure and the possible effects of glycosaminoglycans].
    Spinar J; Novotný J; Mayer J; Vítovec J; Spinarová L
    Vnitr Lek; 1995 Jan; 41(1):3-7. PubMed ID: 7716890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of fibrinogen in an Italian population suffering from claudication. Lower fibrinogen in the south compared to middle and north of Italy. The ADEP Group.
    Basili S; Milani M; Longoni A; Vieri M; Iuliano L; Violi F
    Haematologica; 1998 Aug; 83(8):701-7. PubMed ID: 9793253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of acipimox and pravastatin in patients with combined hyperlipidemia.
    Fogari R; Marasi G; Vanasia A; Zoppi A; Lusardi P; Preti P
    Int J Clin Pharmacol Ther; 1997 Feb; 35(2):61-4. PubMed ID: 9147709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.